[1]
|
C. Arpin, C. Coze, A. M. Rogues, J. P. Gachie, C. Bebear and C. Quentin, “Epidemiological Study of an Outbreak Due to Multidrug-Resistant Enterobacter aerogenes in a Medical Intensive Care Unit,” Journal of Clinical Microbiology, Vol. 34, No. 9, 1996, pp. 2163-2169.
|
[2]
|
S. E. Cosgrove, K. S. Kaye, G. M. Eliopoulous and Y. Carmeli, “Health and Economic Outcomes of the Emergence of Third-Generation Cephalosporin Resistance in Enterobacter Species,” Archives of Internal Medicine, Vol. 162, No. 2, 2002, pp. 185-190.
doi:10.1001/archinte.162.2.185
|
[3]
|
S. Jalaluddin, J. M. Devaster, R. Scheen, M. Gerard and J. P. Butzler, “Molecular Epidemiological Study of Nosocomial Enterobacter aerogenes Isolates in a Belgian Hospital,” Journal of Clinical Microbiology, Vol. 36, No. 7, 1998, pp. 1846-1852.
|
[4]
|
W. E. Sanders Jr. and C. C. Sanders, “Enterobacter spp.: Pathogens Poised to Flourish at the Turn of the Century,” Clinical Microbiology Reviews, Vol. 10, No. 2, 1997, pp. 220-241.
|
[5]
|
P. E. Coudron, E. S. Moland and C. C. Sanders, “Occurrence and Detection of Extended-Spectrum Beta-Lactamases in Members of the Family Enterobacteriaceae at a Veterans Medical Center: Seek and You May Find,” Journal of Clinical Microbiology, Vol. 35, No. 10, 1997, pp. 2593-2597.
|
[6]
|
L. B. Rice, S. H. Willey, G. A. Papanicolaou, A. A. Medeiros, G. M. Eliopoulos, R. C. Moellering Jr. and G. A. Jacoby, “Outbreak of Ceftazidime Resistance Caused by Extended-Spectrum Beta-Lactamases at a Massachusetts Chronic-Care Facility,” Antimicrobial Agents and Chemotherapy, Vol. 34, No. 11, 1990, pp. 2193-2199.
|
[7]
|
L. A. Minarini, E. C. Clímaco, D. B. Guimar?es, J. C. Ferreira, I. C. Palazzo, R. Martinez and A. L. Darini, “Clonal Transmission of ESBL-Producing Klebsiella spp. at a University Hospital in Brazil,” Current Microbiology, Vol. 56, No. 6, 2008, pp. 587-591.
doi:10.1007/s00284-008-9129-5
|
[8]
|
N. D. Hanson, “AmpC Beta-Lactamases: What Do We Need to Know for the Future?” Journal of Antimicrobial Consumption, Vol. 52, No. 1, 2003, pp. 2-4.
doi:10.1093/jac/dkg284
|
[9]
|
R. Bonnet, “Growing Group of Extended-Spectrum Beta-Lactamases: The CTX-M Enzymes,” Antimicrobial Agents and Chemotherapy, Vol. 48, No. 1, 2004, pp. 1-14.
doi:10.1128/AAC.48.1.1-14.2004
|
[10]
|
J. S. Weese, “Investigation of Enterobacter cloacae Infections at a Small Animal Veterinary Teaching Hospital,” Veterinary Microbiology, Vol. 130, No. 3-4, 2008, pp. 426-428. doi:10.1016/j.vetmic.2008.02.009
|
[11]
|
L. Bret, C. Chanal-Claris, D. Sirot, E. B. Chaibi, R. Labia and J. Sirot, “Chromosomally Encoded AmpC-Type Beta-Lactamase in a Clinical Isolate of Proteus mirabilis,” Antimicrobial Agents and Chemotherapy, Vol. 42, No. 5, 1998, pp. 1110-1114.
|
[12]
|
C. Dutour, R. Bonnet, H. Marchandin, M. Boyer, C. Chanal, D. Sirot and J. Sirot, “CTX-M-1, CTX-M-3, and CTX-M-14 Beta-Lactamases from Enterobacteriaceae Isolated in France,” Antimicrobial Agents and Chemotherapy, Vol. 46, No. 2, 2002, pp. 534-537.
doi:10.1128/AAC.46.2.534-537.2002
|
[13]
|
M. Quinteros, M. Radice, N. Gardella, M. M. Rodriguez, N. Costa, D. Korbenfeld, E. Couto and G. Gutkind, “Extended-Spectrum Beta-Lactamases in Enterobacteriaceae in Buenos Aires, Argentina, Public Hospitals,” Antimicrobial Agents and Chemotherapy, Vol. 47, No. 9, 2003, pp. 2864-2867. doi:10.1128/AAC.47.9.2864-2867.2003
|
[14]
|
J. Schlesinger, S. Navon-Venezia, I. Chmelnitsky, O. Hammer-Munz, A. Leavitt, H. S. Gold, M. J. Schwaber and Y. Carmeli, “Extended-Spectrum Beta-Lactamases among Enterobacter Isolates Obtained in Tel Aviv, Israel,” Antimicrobial Agents and Chemotherapy, Vol. 49, No. 3, 2005, pp. 1150-1156.
doi:10.1128/AAC.49.3.1150-1156.2005
|
[15]
|
J. D. Pitout, D. B. Gregson, D. L. Church, S. Elsayed and K. B. Laupland, “Community-Wide Outbreaks of Clonally Related CTX-M-14 Beta-Lactamase-Producing Escherichia coli Strains in the Calgary Health Region,” Journal of Clinical Microbiology, Vol. 43, No. 6, 2005, pp. 2844-2849. doi:10.1128/JCM.43.6.2844-2849.2005
|
[16]
|
X. Bertrand, D. Hocquet, K. Boisson, E. Siebor and P. Plesiat, D. Talon, “Molecular Epidemiology of Enterobacteriaceae Producing Extended-Spectrum Beta-Lactamase in a French University-Affiliated Hospital,” The International Journal of Antimicrobial Agents, Vol. 22, No. 2, 2003, pp. 128-133.
doi:10.1016/S0924-8579(03)00098-0
|
[17]
|
C. Neuwirth, E. Siebor, J. Lopez, A. Pechinot and A. Kazmierczak, “Outbreak of TEM-24-Producing Enterobacter aerogenes in an Intensive Care Unit and Dissemination of the Extended-Spectrum Beta-Lactamase to Other Members of the Family Enterobacteriaceae,” Journal of Clinical Microbiology, Vol. 34, No. 1, 1996, pp. 76-79.
|
[18]
|
O. Lesens, Y. Hansmann, P. Riegel, R. Heller, M. Benaissa-Djellouli, M. Martinot, H. Petit and D. Christmann, “Bacteremia and Endocarditis Caused by a Gordonia Species in a Patient with a Central Venous Catheter,” Emerging Infectious Diseases, Vol. 6, No. 4, 2000, pp. 382-385.
doi:10.3201/eid0604.000410
|
[19]
|
J. Duchon, P. Graham III, P. Della-Latta, S. Whittier, D. Carp, D. Bateman and L. Saiman, “Epidemiology of Enterococci in a Neonatal Intensive Care Unit,” Infection Control & Hospital Epidemiology, Vol. 29, No. 4, 2008, pp. 374-376. doi:10.1086/533544
|
[20]
|
E. Tzelepi, P. Giakkoupi, D. Sofianou, V. Loukova, A. Kemeroglou and A. Tsakris, “Detection of Extended-Spectrum Beta-Lactamases in Clinical Isolates of Enterobacter cloacae and Enterobacter aerogenes,” Journal of Clinical Microbiology, Vol. 38, No. 2, 2000, pp. 542-546.
|
[21]
|
A. Y. Peleg and D. C. Hooper, “Hospital-Acquired Infections Due to Gram-Negative Bacteria,” The New England Journal of Medicine, Vol. 362, No. 19, 2010, pp. 1804-1813. doi:10.1056/NEJMra0904124
|